Displaying 1181 - 1200 of 1557
Announced Actions for January 14, 2005
Cephalon, Inc., and CIMA Labs, Inc.
The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer pain drug, Actiq, in the United States.
Protecting Competition, FTC Clears Genzyme Corp.'s $1 Billion Acquisition of Ilex Oncology, Inc.
Administrative Law Judge Upholds FTC Complaint Against North Texas Specialty Physicians
Sanofi-Synthelabo and Aventis, In the Matter of
The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.
Announced Actions for October 5, 2004
Piedmont Health Alliance, Inc., et al., In the Matter of
With an administrative complaint issued on December 22, 2003 the Commission charged Piedmont Health Alliance, Inc. with collectively setting prices it demanded for physician services with third party payers. According to the complaint, the physician-hospital organization entered into signed agreements on behalf of its member physicians to participate in all contracts negotiated and to accept the negotiated physician fees. The complaint further alleges that these practices eliminated price competition among physicians in the North Carolina counties of Alexander, Burke, Caldwell and Catawba. The complaint also names ten individual physicians who participated in the alleged price fixing services. On August 10, 2004, the organization and physicians agreed to settle charges. Also refer to settlement entered with Tenet Healthcare Corporation (Frye Regional Medical Center, Inc.).
New Mexico PHO, Physician Group, and Their Agent Settle FTC Price-Fixing Charges
Announced Actions for September 24, 2004
FTC Staff: California Bill May Raise Prices for Pharmaceuticals
Generic Drug Marketers Settle FTC Charges
Piedmont Health Alliance Settles FTC Price-fixing Charges
With Conditions, FTC Allows Cephalons Purchase of CIMA, Protecting Competition for Breakthrough Cancer Pain Drugs
Announced Action for August 6, 2004
Southeastern New Mexico Physicians IPA, Inc., a corporation, and Barbara Gomez and Lonnie Ray, individually
A Roswell, New Mexico physicians’ association, Southeastern New Mexico Physicians IPA, settled charges that it and two of its employees entered into collective agreements among physician members on fees and refused to deal with health plans that did not accept the collective agreed-upon terms. According to the complaint, these practices increased the price of health care in the Roswell area. The consent order prohibits the IPA and its employees named in the consent from orchestrating agreements between physicians to negotiate with health insurance plans on behalf of any physician and deal or refuse to deal individually with any third party payer.
FTC Denies State Dental Boards Dismissal Motion on State Action Grounds
Resolving Anticompetitive Concerns, FTC Clears Sanofi-Synthlabos Acquisition of Aventis
FTC and DOJ Issue Report on Competition and Health Care
Displaying 1181 - 1200 of 1557